BSGM Logo

BioSig Technologies, Inc. (BSGM) 

NASDAQ
Market Cap
$25.51M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
581 of 959
Rank in Industry
70 of 120

Largest Insider Buys in Sector

BSGM Stock Price History Chart

BSGM Stock Performance

About BioSig Technologies, Inc.

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial …

Insider Activity of BioSig Technologies, Inc.

Over the last 12 months, insiders at BioSig Technologies, Inc. have bought $0 and sold $0 worth of BioSig Technologies, Inc. stock.

On average, over the past 5 years, insiders at BioSig Technologies, Inc. have bought $268,466 and sold $530,371 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 15,600 shares for transaction amount of $19,358 was made by LONDONER KENNETH L (Chief Executive Officer) on 2023‑06‑13.

List of Insider Buy and Sell Transactions, BioSig Technologies, Inc.

2023-06-13PurchaseChief Executive Officer
15,600
0.025%
$1.24$19,358-54.68%
2023-06-12PurchaseChief Executive Officer
6,000
0.0094%
$1.17$7,040-53.03%
2023-06-02PurchaseChief Executive Officer
4,600
0.0078%
$1.37$6,292-56.10%
2023-05-31PurchaseChief Executive Officer
8,000
0.0132%
$1.57$12,560-62.18%
2023-02-08PurchaseChief Financial Officer
232,882
0.0003%
$0.86$199,999-31.84%
2022-09-07PurchaseChief Executive Officer
1,000
0.0022%
$0.83$830+5.37%
2022-09-02PurchaseChief Executive Officer
1,000
0.002%
$1.00$1,000-19.72%
2022-09-01PurchaseChief Executive Officer
17,240
0.0368%
$1.08$18,704-22.35%
2022-09-01PurchaseChief Financial Officer
11,425
0.0254%
$1.13$12,929-22.35%
2022-08-30PurchaseChief Operating Officer
5,000
0.0113%
$1.07$5,335-16.19%
2022-08-29PurchaseChief Executive Officer
6,100
0.0137%
$1.10$6,710-19.13%
2022-08-25PurchaseChief Executive Officer
1,000
0.0022%
$1.12$1,120-23.08%
2022-08-24Purchase
17,000
0.0391%
$1.16$19,720-20.96%
2022-08-24PurchaseChief Operating Officer
10,000
0.0225%
$1.13$11,347-20.96%
2022-08-24PurchaseChief Commercial Officer
36,036
0.0843%
$1.18$42,522-20.96%
2022-08-23PurchaseChief Executive Officer
2,000
0.0046%
$1.10$2,200-16.90%
2022-08-22PurchaseChief Financial Officer
8,000
0.0175%
$1.13$9,016-20.83%
2022-08-19PurchaseChief Executive Officer
4,000
0.0085%
$1.00$4,000-11.13%
2022-08-17PurchaseChief Executive Officer
6,000
0.0137%
$0.99$5,940-1.19%
2022-08-16PurchaseChief Executive Officer
4,100
0.0088%
$0.96$3,936-2.58%

Insider Historical Profitability

3.88%
LONDONER KENNETH LChief Executive Officer
2507020
14.5462%
$1.4810875+0.43%
CHAUSSY STEVEChief Financial Officer
1051553
6.1013%
$1.48230+14.3%
FOLEY DONALD Edirector
255000
1.4796%
$1.4820+9.74%
BUHALY STEVEN JChief Financial Officer
232882
1.3512%
$1.4810<0.0001%
ODONNELL JEFFREY Fdirector
151629
0.8798%
$1.4812<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$45,469.000.4968,788-97.11%-$1.53M<0.0001
BlackRock$40,046.000.4360,584-90.06%-$362,853.09<0.0001
Geode Capital Management$37,529.000.456,762-89.97%-$336,806.28<0.0001
Jane Street Capital$28,962.000.3143,815+148.89%+$17,325.64<0.0001
Hrt Financial Llc$17,000.000.1926,331New+$17,000.00<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.